Panel Discussion: Game Changers in the Product Life Cycle
Tuesday, February 20, 2024 3:00 PM to 4:00 PM · 1 hr. (Europe/Prague)
Bohemia Suite
Panel Discussion
Information
The panel session will be discussions on the following areas:
- Preclinical development: in silico models for investigating metabolism and toxicity of candidate drugs
- Artificial Intelligence
- European Health Data Space
Speakers
MO
Martin O'Kane
Regional Head, Regulatory Affairs EU Policy & LiaisonNovartis
Doug Peddicord
Executive DirectorACRO
Lenka Kaska
Corporate Affairs DirectorPfizer
Jana Brajdih Cendak
Medical and Pharmacovigilance LeadBillev Pharma East
Gabriele Schwarz
GCP Strategy ExpertGerman Federal Institute for Drugs and Medical Devices
Viviënne van de Walle
PI / directorPTR
Sally Hofmeister
Board Member/Duchenne Community Advisory Board CoordinatorWorld Duchenne OrganisationPanel Discussion: Game Changers in the Product Life Cycle
Preclinical development: in silico models for investigating metabolism and toxicity of candidate drugs
Tuesday, February 20, 2024 2:30 PM to 2:40 PM
Bohemia Suite
Jana Brajdih Cendak · Billev Pharma East
How the European Health Data Space world will look
Tuesday, February 20, 2024 2:40 PM to 2:55 PM
Bohemia Suite
Lenka Kaska · Pfizer


